ask="4.49"
ask_size="1600"
average_daily_volume="45452"
bid="3.76"
bid_size="100"
book_value="5.08"
change="-0.02"
change_from_200_day_moving_average="-1.66"
change_from_50_day_moving_average="-0.91"
change_from_52_week_high="-8.76"
change_From_52_week_low="0.33"
change_in_percent="-0.50%"
close="3.99"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-8.61"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="6404000"
high="4.23"
high_52_weeks="12.75"
last_trade_date="1/31/2017"
last_trade_price="3.99"
last_trade_size="200"
last_trade_time="4:00pm"
low="3.66"
low_52_weeks="3.66"
market_capitalization="53.59M"
moving_average_200_day="5.65"
moving_average_50_day="4.90"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="17.00"
open="4.08"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-29.42%"
percent_change_from_50_day_moving_average="-18.64%"
percent_change_from_52_week_high="-68.71%"
percent_change_from_52_week_low="+9.02%"
previous_close="4.01"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.79"
price_per_sales="10.84"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="1.42"
stock_exchange="NGM"
symbol="AGLE"
volume="71942"
weeks_range_52="3.66 - 12.75"
